Brief: Ceapro Reports Third Quarter Financial Results
Nov 9 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO INC. REPORTS 2022 THIRD QUARTER AND NINE-MONTH
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* CEAPRO INC- QTRLY EPS $0.01
Source text for Eikon: ID:nGNX6ZScl6
Further company coverage: CZO.V
((reuters.briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases